OTC: COGZF - Cogstate Limited

Rentabilität für sechs Monate: +40.35%
Dividendenrendite: 0.00%
Sektor: Healthcare

Aktionsplan Cogstate Limited

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen Cogstate Limited

Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. The company's cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments.

weitere details
The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2022, it had participated in approximately 1,800 academic research. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

Industry Health Care Technology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.cogstate.com
Цена ао 0.84
Preisänderung pro Tag: 0% (0.8)
Preisänderung pro Woche: -6.98% (0.86)
Preisänderung pro Monat: +14.29% (0.7)
Preisänderung über 3 Monate: +25% (0.64)
Preisänderung über sechs Monate: +40.35% (0.57)
Preisänderung pro Jahr: +1.27% (0.79)
Preisänderung über 3 Jahre: -36.51% (1.26)
Preisänderung über 5 Jahre: +155.18% (0.3135)
Preisänderung über 10 Jahre: 0% (0.8)
Preisänderung seit Jahresbeginn: +26.98% (0.63)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 2.87 6
P/BV 3.05 5
P/E 22.88 6
EV/EBITDA 0 0
Gesamt: 6.13

Effizienz

Name Bedeutung Grad
ROA, % 9.74 3
ROE, % 13.87 4
Gesamt: 2.83

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0

Pflicht

Name Bedeutung Grad
Debt/EBITDA 0 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 25.88 4
Rentabilität Ebitda, % -221.06 0
Rentabilität EPS, % -382.41 0
Gesamt: 0.8
Weitere Details

Institutionen Volumen Aktie, %
Bard Financial Services, INC. 12500 0.01



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Prof. Paul Maruff BBSc (Hons), Ph.D. Founder & Chief Innovation Officer N/A
Mr. Darren Watson Chief Financial Officer 356.18k
Mr. Kenneth Billard Chief Commercial Officer 417.18k
Ms. Rachel Colite Executive VP of Clinical Trials 290.87k
Ms. Kristi Geddes General Counsel, Joint Company Secretary & Director N/A
Mr. David James Franks BEc, C.A., F Fin, J.P. Joint Company Secretary N/A 1970 (55 Jahre)
Mr. Bradley John O'Connor B.Bus, C.A., CA CEO, MD & Executive Director

Adresse: Australia, Melbourne. VIC, 367 Collins Street - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.cogstate.com